PKP2, a cardinal structural component of cardiomyocyte IDs, has been extensively characterized as a genetic determinant in ARVC, with loss‐of‐function mutations accounting for approximately 40% of familial ARVC cases [24, 25]. Here, PKP2 is linked to arrhythmogenic right ventricular cardiomyopathy.